MediLink reports phase III results for Tam-Peli demonstrating significant overall survival benefits in Chinese small-cell lung cancer patients, per GlobeNewswire.
Browsing Category
Healthcare operations
42 posts
Enhancing Social Care Efficiency With Automated Benefit Check Technology
New AI-driven benefit check bot aims to streamline eligibility screening for low-income families, filling a gap left by recent nonprofit closures.
The Future Of Phone Addiction Recovery In Cohort-Based Settings
A new eight-week cohort program for adult phone addiction aims to address gaps in current recovery options, with pilot testing beginning soon.
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of LEQEMBI® (Lecanemab) For Early Alzheimer’s Disease
Canada’s drug regulator issues final positive recommendation to support public reimbursement of Leqembi (lecanemab) for early Alzheimer’s disease, impacting patient access.
HUAWEI WATCH D3 Makes Early Debut At ESC Congress 2026: A New Era In Wrist-Based Blood Pressure Management
Huawei unveils the Watch D3 at ESC Congress 2026, marking a significant step in wrist-based blood pressure management technology. Details are confirmed but full specs are pending.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces that the SANOVO trial shows notable progression-free survival benefits with ORPATHYS® plus TAGRISSO® in lung cancer patients in China.
Exploring The Impact Of Phone Technology On Dental Aesthetics
New developments in phone camera shade scoring aim to objectively measure teeth whitening progress, potentially changing home dental care.
Rznomics Joins Lilly Gateway Labs In San Diego To Accelerate RNA Therapeutics
Rznomics has joined Lilly Gateway Labs in San Diego to accelerate the development of RNA-based therapeutics, marking a strategic collaboration in biotech innovation.
Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Anbogen Therapeutics and The University of Tokyo have signed a collaborative research agreement to evaluate ABT-301 across multiple tumor types, aiming to accelerate clinical development.
Daily Oral Health Photos: A Simple Strategy For Dental Gap Prevention
A new approach using daily gum-line photos aims to prevent dental gaps by tracking early signs of inflammation between visits, with promising initial testing.